Strip the marketing fluff and the distinction is simple.

White label is a stock formula — a tube of cream, a capsule of greens powder, a bottle of CBD tincture — that the manufacturer has already developed, validated, and placed on a shelf. You pick the format, drop your label on the bottle, ship it. The product inside is identical to the product the next buyer is putting under their own logo. Same fill, same cost line, same COA. White-label SKUs exist so a brand can be in-market in 4-6 weeks instead of 14-22.

Private label means the manufacturer is producing for you specifically — sometimes off a stock base they've adjusted, sometimes off a fresh formula scoped against your brief. The output is yours. The factory is not selling that exact recipe to your competitor next month. Private label sits one rung above white label and one rung below full contract manufacturing, where every ingredient, source, and step is custom.

The reason this gets confusing is that the supplements industry, the cosmetics industry, and the pet-care industry all use the terms differently. A capsule manufacturer in Utah will tell you "private label" means a tweaked stock formula. A skincare lab in California will tell you "private label" means a fully custom emulsion. Same words, different commercial reality.

Here is where founders get burned.

Most "private label" engagements at the lower end of the market are not exclusive. The factory has built a base formula — say, a magnesium glycinate 400mg — and they're happy to call it your private-label SKU and put your name on the box. They are also happy to do the exact same thing for the next four founders who walk in with the same sourcing brief. Three months later you're competing on Amazon against a SKU that has the identical fill, identical capsule, and identical certifications, just with a different brand on the front.

True exclusivity comes from one of three things: (1) a custom formulation written under a development agreement, (2) a contractual exclusivity window that you pay for, or (3) volume large enough that the factory chooses not to share the line. None of these come automatically with the words "private label."

Ask directly: "Is this formula being run for any other buyers under their own brand?" If the answer is yes, you're in a white-label engagement that has been re-named. That is not necessarily bad — the SKU might still hit margin and ship in 6 weeks. But you should know what you're buying.

If the factory says "we'll make a small modification for you and call it private label," that's a real category. The fix is to ask what the modification actually is — flavor change, dosage tweak, adding a single ingredient. Then ask whether that modification creates exclusivity. The answer is usually no, but at least you know.

The numbers below are typical industry ranges across supplements, cosmetics, and food & beverage. Not every facility quotes against them. They're a sanity check, not a price list.

White label. Minimum order quantity (MOQ) typically starts at 100-500 units for cosmetics and 500-1,000 units for supplements. Lead time is 3-6 weeks because the formula and packaging have already been validated — the factory is essentially printing your label and routing existing stock through your packaging. Per-unit cost runs at the low end because there is no formulation work to amortize.

Private label (stock-base modification). MOQ usually moves up to 500-1,500 units. Lead time stretches to 6-10 weeks because the factory has to schedule a dedicated run, source any modified ingredients, and run a small stability check. Per-unit cost rises 8-25 percent over white label depending on what the modification is.

Private label (custom-formulated). MOQ enters 1,000-5,000 territory and lead time stretches 14-22 weeks once formulation, stability testing, and label-claim validation are added. Per-unit cost is the highest of the three but margin can be the best because you control the spec.

None of those ranges are absolute. Powder formats, gummy formats, and liquid formats price very differently. Cosmetic emulsions price differently again. The cost driver that matters most is fill weight against your target retail price. We've seen private-label SKUs with healthier margins than white-label competitors because the founder picked a fill that hit a tighter cost-of-goods.

This is where the FDA, the FTC, and 21 CFR Part 111 quietly punish people who copied a competitor's label without thinking.

The product on a white-label run is, by definition, not exclusive to you. You can put your logo on it. You can put your color story on it. What you cannot do is claim formulation authorship — "our scientifically formulated blend," "our proprietary complex" — because the formula is somebody else's. Whether anyone catches you depends on category, but on a class-action plaintiff bar's view, white-label "proprietary" claims are a gift.

Private-label runs give you more room. If the formula was modified meaningfully, you can describe it as your formulation. If the formula was custom-developed under a written agreement, you absolutely can. But the bar is still real: every claim on the label has to be substantiated. The FDA's Dietary Supplement Labeling Guide is the canonical reference for what's allowed in supplement claims, and the FTC's Advertising Guide for Dietary Supplements is the canonical reference for what you can say in marketing copy.

If you sell into Amazon's Brand Registry, the question gets sharper. Brand Registry expects an exclusive product or a meaningfully differentiated one. White-label SKUs that are also being sold by three other brands are a Brand Registry risk and a hijacker risk both at once. Private label with a real spec change reduces both risks.

White label wins when speed and proof-of-concept matter more than differentiation. You're testing whether a market exists. You want a SKU on Shopify in 5 weeks so you can run a paid campaign and see what the click-through to purchase actually is. The product does not need to be defensible yet. It needs to exist.

White label also wins when you are filling out a category — a brand that already sells four hero SKUs and wants a fifth that nobody is going to scrutinize. Bundling, gifting kits, retailer-specific accessory SKUs. The white-label tail of a brand can quietly carry a meaningful share of revenue.

Private label wins when the SKU is the brand. If your hero product is the thing customers tell their friends about, you cannot afford to be running the same formula as four other competitors. A private-label engagement with a real formula change — even a small one — gives you a defensible position on Amazon, in retail, and on a co-manufacturer's audit trail.

Private label also wins when you have specific compliance demands. Organic certification, NSF Certified for Sport, vegan-only ingredient deck, particular allergens excluded. White-label stock formulas can be NSF or organic, but you're constrained to whatever the factory chose to certify. With private label you specify.

The hybrid case — and we see this often — is to launch on white label, validate the market, then commission a private-label or contract-manufactured v2 once you know which SKUs are pulling. The white-label v1 funds the v2.

Anyone selling you a "private label" engagement should answer all of these without flinching. If they don't, you're in a white-label engagement that's been wallpapered.

1. Is the formula being run for any other buyer under their own brand? Plain yes-or-no.
2. If yes, how many other brands are running this exact formula in 2026? Establishes how crowded the SKU is in retail.
3. What modifications, if any, are you making for me? Determines whether this is real private label or relabeled white label.
4. What's the COA cadence — every batch, every quarter, on demand? Affects what you can substantiate to a retailer or insurer.
5. What's the certification posture — GMP-aware, GMP-certified, NSF, organic? Different price points, different audit liability. The Natural Products Association publishes the most widely cited GMP standard for supplements.
6. What's the reorder MOQ vs the first-run MOQ? Often very different. First runs are bigger so the factory can amortize setup.
7. What's the exclusivity option, if any, and what does it cost? Sometimes a formal exclusivity window is available for a small uplift on cost-per-unit.
8. Who owns the formulation document? If you commission a custom formula, the development agreement should answer this. White-label and stock-base private label keep the formula with the factory.

Get those answers in writing on the same email thread as the quote. If the factory hedges, you have your answer.

Mistake 1: confusing speed with quality. A 4-week white-label launch is not lower-quality than a 16-week private-label launch. They're optimizing for different things. The white-label run gives you data; the private-label run gives you a moat. Both have a place.

Mistake 2: signing a "private label" agreement without reading the formula clause. The clause about whether the formula is exclusive, who owns it, and what happens at the end of the engagement is more important than the per-unit price.

Mistake 3: scaling on white label. You launched on white label, the SKU is selling, and you're tempted to just keep ordering. At the point where the brand actually matters, the formula being identical to three competitors becomes a liability. The migration to private label or contract manufacturing should happen before that liability shows up — not after.

Mistake 4: under-spec'ing the packaging. Both routes leave packaging to the buyer. We've seen white-label launches where the formula was great and the bottle was wrong — the same bottle four other brands were using, and a generic dropper that leaked. Packaging is where white-label SKUs differentiate.

Mistake 5: assuming MOQs are fixed. They are fixed in the quote. They are not fixed across the relationship. After a successful first run, factories will negotiate. The reorder MOQ should always be lower than the first-run MOQ.

Three steps, in order.

One: write the brief. Format, fill weight, indicative retail price, certification asks, target launch date. One page. The brief tells you whether your project even fits white label — sometimes the launch math forces private label by default because no white-label SKU hits your spec.

Two: get three quotes. One white-label, one stock-base private label, one custom private label. Compare side by side. Per-unit cost, MOQ, lead time, certification posture, exclusivity. The right answer is rarely the cheapest one.

Three: pressure-test the answer. Run the cost-per-unit through your gross-margin model at each volume tier. The picture changes. A white-label SKU at $2.20/unit might lose to a private-label SKU at $2.80/unit because the private-label run gives you a 12-month exclusivity window that prevents margin compression.

If you want to skip the discovery work, brief us. We've placed both white-label and private-label runs across supplements, cosmetics, food & beverage, and pet care, and we'll come back inside 36 hours with three sourcing routes priced against the same brief — so you can see what each engagement actually costs before you commit.